News Daily News Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests Michael O'Riordan December 03, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Daily News Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows Michael O'Riordan November 06, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Daily News Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy Michael O'Riordan October 25, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Conference News ESC 2018 Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE Michael O'Riordan August 28, 2018
News Daily News Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases Michael O'Riordan August 16, 2018
News Daily News USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment Michael O'Riordan July 12, 2018
News Daily News Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle Michael O'Riordan June 18, 2018
News Daily News PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations Michael O'Riordan May 10, 2018
News Conference News EAS 2018 Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction Yael L. Maxwell May 08, 2018
News Conference News EAS 2018 Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention Yael L. Maxwell May 07, 2018
News Daily News Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say Michael O'Riordan April 09, 2018
News Conference News ACC 2018 Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis Michael O'Riordan March 14, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Daily News Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke Michael O'Riordan February 07, 2018